🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT05390216
Active, not recruiting Not applicable

Impact of Partial Capsule Decortication on Device-related Infection in Patients Receiving Cardiac Implantable Electronic Device Replacement

NCT05390216 · tracked via the Priya Life Science China tracker
Sponsor
Shanghai Zhongshan Hospital
Phase
Not applicable
Started
2022-06-05
Last updated
2024-06-24

Condition(s) studied

Pacemaker ComplicationInfections

Investigational drug(s) / intervention(s)

Partial capsule decortication

Partial capsule decortication: The anterior wall of the capsule was removed during the operation.

Study summary

Increasing number of cardiac implantable electronic devices (CIEDs) have been implanted in the worldwide every year, which is accompanied by the growing number of CIED-related infection, especially in patients with CIED replacement. This multicenter, prospective, single-blinded, randomized controlled trial is to confirm the impact of partial capsule decortication on device-related infection in patients receiving CIED replacement.

Eligibility

Sex
ALL
Min age
18 Years
Max age
Healthy volunteers
Accepted
Inclusion Criteria: * Patient is at least 18 years of age * Patient is planned to undergo at least one of the following procedures: a) Patient has existing CIED (pacemaker, or CRT-P, or ICD, or CRT-D) and is undergoing pulse generator replacement or upgrade with a new generator. b) Patients planned to have leads added, or extracted and added for upgrades. * Patient is willing to sign and date informed consent Exclusion Criteria: * History of CIED-related infection * Open the pocket for any reason within the last one year * Any evidence indicating active infection * Requirement of long term vascular access for any reason * Expected survival time is less than one year * Patients who were pregnant or breastfeeding * Participation in another study that may confound the results of this study * Patient is unable to comply with scheduled follow up

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
180 Fenglin Road Shanghai Shanghai Municipality

More Shanghai Zhongshan Hospital trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05390216 on ClinicalTrials.gov ↗ ← All trials in China